Millie Capital Management’s Pfizer PFE Stock Holding History

Millie Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$328K	Hold	9,541	–	–	0.28%	61
2017 Q3	$323K	Hold	9,541	–	–	0.26%	56
2017 Q2	$304K	Sell	9,541 -3,816	-29%	-$120K	0.26%	57
2017 Q1	$434K	Sell	13,357 -2,414	-15%	-$76.1K	0.41%	51
2016 Q4	$486K	Sell	15,771 -20,369	-56%	-$622K	0.49%	49
2016 Q3	$1.16M	Buy	36,140 +5,060	+16%	+$169K	1.28%	31
2016 Q2	$1.04M	Buy	31,080 +2,624	+9%	+$83.7K	1.1%	38
2016 Q1	$800K	Buy	28,456 +732	+3%	+$20.9K	0.86%	38
2015 Q4	$849K	Hold	27,724	–	–	0.89%	43
2015 Q3	$826K	Buy	27,724 +11,626	+72%	+$373K	0.75%	47
2015 Q2	$512K	Hold	16,098	–	–	0.47%	50
2015 Q1	$531K	Hold	16,098	–	–	0.5%	50
2014 Q4	$476K	Buy	+16,098	New	+$462K	0.49%	51

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millie Capital Management's PFE Position: Q4 2017 in Review

Millie Capital Management held its Pfizer (PFE) position steady in Q4 2017 at 9,541 shares worth $328K. The position accounts for 0.28% of the portfolio, ranked #61.

Millie Capital Management first reported a position in PFE in Q4 2014 and has held it in 13 quarters since. The position peaked at $1.16M in Q3 2016. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Millie Capital Management held 9,541 shares of Pfizer worth $328K as of Q4 2017.
Millie Capital Management left its Pfizer share count unchanged in Q4 2017.
Pfizer made up 0.28% of Millie Capital Management's portfolio in Q4 2017, its #61 holding.
Millie Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 13 quarters since.
Millie Capital Management's Pfizer position peaked at $1.16M in Q3 2016.
2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Millie Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.